Insecticides (India) to Consider FY27 Interim Dividend Nov 5
Key highlights
- Insecticides (India) will hold its board meeting on November 5, 2026, to consider Q2 and H1 FY27 results and a possible interim dividend.
- November 12, 2026, is the record date for the proposed FY27 interim dividend, subject to board approval.
- Standalone June 2026 net sales were ₹616.48 crore, down 10.83% year on year.
- Insecticides (India) will hold its Q2 and H1 FY27 earnings call at 5:00 pm IST on November 5, 2026.
powered by IRIS

Insecticides (India) Limited will consider an interim dividend for FY 2026-27 at its November 5, 2026 board meeting, alongside Q2 and H1 results, after standalone June-quarter net sales declined 10.83% year on year to ₹616.48 crore, with November 12 set as the contingent record date.
Know Insecticides India inside out
Results, valuation, peers and who's buying, in one view.
What will Insecticides (India) consider at the November 5 board meeting?
Insecticides (India) will consider and approve its financial results for the quarter and half year ended September 30, 2026, and may also consider declaring an interim dividend for FY 2026-27. The company disclosed the agenda through its exchange filing, which states that the dividend proposal remains subject to the board's decision.
The company has set Thursday, November 12, 2026, as the record date to determine shareholder eligibility if the board declares the dividend. A record date identifies shareholders entitled to receive a declared corporate action, based on the applicable settlement and depository process. The November 12 date does not by itself confirm a payout or specify the amount of any FY27 interim dividend.
The meeting is scheduled for Thursday, November 5. Its agenda combines results, dividend consideration and other business matters, making the financial disclosures relevant to investors assessing the board's capital-distribution decision.
When will Insecticides (India) release Q2 and H1 FY27 results?
Insecticides (India) will release unaudited standalone and consolidated financial results for Q2 and H1 FY27 on November 5, 2026. The reported period covers the quarter and six months ended September 30, 2026, which is the company's second quarter of the financial year ending March 2027.
Management will discuss the results with investors and analysts in an earnings conference call at 5:00 pm IST on the same day. The company has indicated that its Managing Director, Chief Financial Officer, Chief Operating Officer and Chief Marketing Officer will participate in the call.
The call gives investors an opportunity to seek management commentary on operating performance during the quarter. However, the filing only confirms the call schedule and result period. It does not provide Q2 or H1 financial figures, dividend quantum, or any forward-looking financial guidance.
Got a follow-up? Ask IRIS
What does the June-quarter performance and dividend history show?
Insecticides (India) reported standalone net sales of ₹616.48 crore for the June 2026 quarter, down 10.83% from the corresponding quarter a year earlier. This is the latest explicitly reported sales figure in the available information before the scheduled September-quarter results.
The supplied quarterly data also shows revenue of ₹612 crore, operating profit of ₹58 crore and net profit of ₹44 crore for June 2026. Operating profit margin was reported at 9.5%, while earnings per share stood at ₹15.08. These figures are presented in the disclosed market-data summary and should be viewed separately from the company's upcoming unaudited Q2 and H1 results.
Insecticides (India) has paid interim dividends in earlier years. The company paid ₹2 per share, representing 20%, with a February 6, 2026 record date. Earlier disclosed interim dividends included ₹2 per share in August 2024 and ₹3 per share in November 2023 and February 2023. Past distributions provide context but do not establish the amount or certainty of a FY27 payout.
Why do the results and dividend decision matter to investors?
Insecticides (India)'s November 5 disclosures matter because they will update investors on performance after the 10.83% year-on-year decline in standalone June-quarter net sales. The September-quarter results will provide the next reported measure of sales, profitability and operational conditions during the first half of FY27.
The dividend decision is also relevant to shareholders because it indicates whether the board chooses to distribute cash midway through the year. The company must first approve a dividend for the November 12 record date to have effect. Investors should therefore distinguish between the announced board agenda, the record-date arrangement and an actual declared dividend.
The available information does not include a share-price reaction, dividend amount, payout ratio or management outlook. Investors following the event can focus on the standalone and consolidated result tables, management's discussion during the 5:00 pm call, and the board's final decision on the interim dividend.
Conclusion
Insecticides (India) has scheduled a November 5 board meeting that brings together Q2 and H1 FY27 financial results and a possible interim dividend decision. The November 12 record date applies only if the board approves a payout, while the June-quarter sales decline of 10.83% provides the latest stated operating reference point before the results.
The next confirmed events are the release of unaudited results and the 5:00 pm IST earnings call on November 5, followed by the November 12 record date if an interim dividend is declared. Investors will watch for the board's dividend decision and management's comments on first-half operating performance.


